Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Effects of MDMA on body temperature in humans.

Liechti ME.

Temperature (Austin). 2014 Oct 31;1(3):192-200. doi: 10.4161/23328940.2014.955433.

2.

MDMA Impairs Response to Water Intake in Healthy Volunteers.

Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE.

Adv Pharmacol Sci. 2016;2016:2175896. doi: 10.1155/2016/2175896.

3.

MDMA for the treatment of mood disorder: all talk no substance?

Patel R, Titheradge D.

Ther Adv Psychopharmacol. 2015 Jun;5(3):179-88. doi: 10.1177/2045125315583786. Review.

4.

Psychostimulants and movement disorders.

Asser A, Taba P.

Front Neurol. 2015 Apr 20;6:75. doi: 10.3389/fneur.2015.00075. Review.

5.

MDMA alters emotional processing and facilitates positive social interaction.

Wardle MC, de Wit H.

Psychopharmacology (Berl). 2014 Oct;231(21):4219-29. doi: 10.1007/s00213-014-3570-x.

6.

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.

Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Biol Psychiatry. 2015 Oct 15;78(8):554-62. doi: 10.1016/j.biopsych.2013.12.015.

8.

Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Schindler CW, Thorndike EB, Blough BE, Tella SR, Goldberg SR, Baumann MH.

Br J Pharmacol. 2014 Jan;171(1):83-91. doi: 10.1111/bph.12423.

9.

Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Neelkantan N, Mikhaylova A, Stewart AM, Arnold R, Gjeloshi V, Kondaveeti D, Poudel MK, Kalueff AV.

ACS Chem Neurosci. 2013 Aug 21;4(8):1137-50. doi: 10.1021/cn400090q. Review.

10.

MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI.

Rouine J, Gobbo OL, Campbell M, Gigliucci V, Ogden I, McHugh Smith K, Duffy P, Behan B, Byrne D, Kelly ME, Blau CW, Kerskens CM, Harkin A.

Br J Pharmacol. 2013 Jul;169(5):974-87. doi: 10.1111/bph.12178.

12.

Substance of abuse and movement disorders: complex interactions and comorbidities.

Deik A, Saunders-Pullman R, Luciano MS.

Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. Review.

13.

Pharmacological treatment of anxiety disorders: current treatments and future directions.

Farach FJ, Pruitt LD, Jun JJ, Jerud AB, Zoellner LA, Roy-Byrne PP.

J Anxiety Disord. 2012 Dec;26(8):833-43. doi: 10.1016/j.janxdis.2012.07.009. Review.

14.

Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.

Halberstadt AL, Buell MR, Price DL, Geyer MA.

Pharmacol Biochem Behav. 2012 Jul;102(1):88-94. doi: 10.1016/j.pbb.2012.03.023.

15.
16.

Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156.

17.

The role of MDMA (Ecstasy) in coping with negative life situations among urban young adults.

Moonzwe LS, Schensul JJ, Kostick KM.

J Psychoactive Drugs. 2011 Jul-Sep;43(3):199-210.

18.

Brain mechanisms of hallucinogens and entactogens.

Vollenweider FX.

Dialogues Clin Neurosci. 2001 Dec;3(4):265-79.

19.

Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Quednow BB, Kometer M, Geyer MA, Vollenweider FX.

Neuropsychopharmacology. 2012 Feb;37(3):630-40. doi: 10.1038/npp.2011.228.

20.

Club drugs: review of the 'rave' with a note of concern for the Indian scenario.

Chakraborty K, Neogi R, Basu D.

Indian J Med Res. 2011 Jun;133:594-604. Review.

Supplemental Content

Support Center